-
NIHR, UKRI fund eight new coronavirus research projects
pharmatimes
September 14, 2020
Eight new research projects investigating the transmission of coronavirus have been awarded a total of £5.3 million by the NIHR and UK Research and Innovation (UKRI), in the hope that findings will help shape COVID-19 policy decisions on prevention and...
-
NII’s COVID-19 vaccine candidate exhibits positive results in immunogenicity study on mice
expresspharma
September 14, 2020
The Director of the Institute said that more tests need to be done on mice on a larger scale now and it is expected to start next week.
-
COVID-19 slashes pharma production in Uttarakhand
expresspharma
September 07, 2020
Uttarakhand based pharma companies have seen a decline in pharma production due to the rapid spread of coronavirus in the state.
-
Vitamin D deficiency may raise risk of getting COVID-19
worldpharmanews
September 04, 2020
In a retrospective study of patients tested for COVID-19, researchers at the University of Chicago Medicine found an association between vitamin D deficiency and the likelihood of becoming infected with the coronavirus.
-
PhIII US trial for AZ' coronavirus vaccine
pharmatimes
September 02, 2020
AstraZeneca has announced the advance of experimental coronavirus vaccine AZD1222 into a Phase III clinical trial in the US to assess its safety, efficacy and immunogenicity in the prevention of COVID-19.
-
NIHR, UKRI stream £8.4m into coronavirus studies
pharmatimes
August 28, 2020
NIHR and UK Research and Innovation (UKRI) are streaming £8.4 million into three new UK-wide research studies aiming to understand immune responses to the novel coronavirus.
-
Europe's largest initiative launches to accelerate therapy development for COVID-19 and future coronavirus threats
worldpharmanews
August 27, 2020
CARE (Corona Accelerated R&D in Europe) a new consortium supported by the Innovative Medicines Initiative (IMI) public-private partnership announced its launch to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2...
-
First coronavirus re-infection reported in Hong Kong, S.A.R., China
pharmatimes
August 26, 2020
Researchers in Hong Kong, S.A.R., China claim to have documented the first confirmed case of coronavirus reinfection.
-
Research links COVID-19 to rise in childhood type 1 diabetes
expresspharma
August 24, 2020
This study analysed data from 30 children in London hospitals diagnosed with new-onset type 1 diabetes during the first peak of the pandemic.
-
Malaysia detects 10x infectious coronavirus strain D614G
biospectrumasia
August 22, 2020
Malaysia has detected a strain of the new coronavirus that’s been found to be 10 times more infectious than the strain currently circulating.